NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/08/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization632.98 mln
Float78.53 mln
Earnings Date05/19/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-8.05
Highly reliable
1-Year Forecast
15.75
Transformational upside
Relative Strength
93
/ 100
Top performer
Debt / Equity
-24.54
Negative equity
ROE
-351
Deeply negative
Business Description
Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through minimally invasive procedures. Its flagship product, the DurAVR system, uses a catheter to deliver an artificial aortic valve designed to closely replicate how a healthy human valve functions. The company also develops tissue preparation technology that reduces calcium buildup in animal-derived materials used for heart surgery, along with a precision delivery tool that helps surgeons navigate the catheter safely through the heart.